Hipra Scientific, S.l.u

This study tested a COVID-19 booster vaccine called BIMERVAX in teenagers aged 12 to 18. The goal was to see how safe it was and how well it boosted the immune system against the virus, especially newer variants. All participants had received two Pfizer shots at least six months …

This study tested a new COVID-19 booster vaccine (called PHH-1V81) to see if it is as safe and effective at creating an immune response as an already approved Pfizer booster. About 913 adults who had already received their initial COVID-19 vaccines and at least one booster partic…

This study tested a new COVID-19 booster shot in adults whose immune systems are weakened by conditions like HIV, kidney disease, or certain medications. The 241 participants received one dose, and researchers tracked their antibody levels and any side effects for a full year. Th…

This study tested a new COVID-19 booster vaccine called PHH-1V. Researchers compared it to the Pfizer booster shot in adults who were already fully vaccinated. The goal was to see if the new vaccine was as safe and effective at triggering an immune response, including against new…